#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13534	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2259	595.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1437	1437	C	740	C	711	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24266	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3520	687.0	0	.	n	.	0	T695C	SNP	695	695	T	999	999	C	728	C,T	675,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24266	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3520	687.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1641	1641	A	839	A	796	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24266	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3520	687.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2275	2275	C	762	C	702	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24266	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3520	687.0	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2901	2901	T	748	T,A	709,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24266	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3520	687.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2349	2349	A	746	A,C	706,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	V36A	NONSYN	106	108	GTG	436	438	GCG	175;175;176	G;C,A;G	166;168,1;170	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	478	480	CGG	163;161;160	C;G;G	153;150;150	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	S68L	NONSYN	202	204	TCG	532	534	TTG	158;158;161	T;T;G	145;145;146	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	A90V	NONSYN	268	270	GCG	598	600	GTT	154;155;153	G;T;T	147;147;148	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	I105V	NONSYN	313	315	ATT	643	645	GTT	153;152;152	G;T;T	141;136;137	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	N125T	NONSYN	373	375	AAT	703	705	ACC	167;168;168	A;C;C	157;157;158	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	R135C	NONSYN	403	405	CGT	733	735	TGT	165;165;163	T,C;G;T,C	149,1;155;149,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	K151E	NONSYN	451	453	AAA	781	783	GAA	143;143;143	G;A;A	137;137;136	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	T152N	NONSYN	454	456	ACC	784	786	AAC	143;145;144	A;A,C;C	133;136,1;137	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	A172T	NONSYN	514	516	GCG	844	846	ACA	125;124;123	A;C;A	121;120;116	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	A175E	NONSYN	523	525	GCG	853	855	GAA	123;125;129	G;A;A	118;118;122	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	E176T	NONSYN	526	528	GAA	856	858	ACC	132;133;133	A,G;C;C	121,1;125;124	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	I178V	NONSYN	532	534	ATC	862	864	GTC	137;138;138	G;T;C	127;124;125	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	I188T	NONSYN	562	564	ATA	892	894	ACG	136;135;133	A;C;G	128;128;124	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	P200N	NONSYN	598	600	CCC	928	930	AAC	148;145;144	A;A;C	141;139;140	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	F220L	NONSYN	658	660	TTT	988	990	TTG	151;152;150	T;T;G	145;145;144	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1045	1047	ACC	134;133;133	A;C;C	128;129;127	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1048	1050	GAC	137;138;139	G;A;C	132;133;132	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1057	1059	GCG	140;143;143	G;C,A;G	131;118,1;133	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1093	1095	GCT	124;131;129	G;C;T	116;122;120	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1534	folP	858	858	91.61	folP.l15.c30.ctg.1	1487	102.7	1	SNP	p	R230S	1	.	.	688	690	AGC	1018	1020	AGC	154;154;156	A;G;C	149;151;150	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4900	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3544	137.9	1	SNP	p	S91F	0	.	.	271	273	TCC	711	713	TCC	181;180;181	T;C;C	174;174;178	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4900	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3544	137.9	1	SNP	p	D95G	0	.	.	283	285	GAC	723	725	GAC	178;176;179	G;A;C	170;168;171	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4900	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3544	137.9	1	SNP	p	D95N	0	.	.	283	285	GAC	723	725	GAC	178;176;179	G;A;C	170;168;171	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1522	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1293	116.9	1	SNP	p	G45D	1	.	.	133	135	GAC	475	477	GAC	203;205;205	G;A;C	188;187;187	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	836	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c4.ctg.1	1096	75.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5004	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2934	169.9	1	SNP	p	D86N	0	.	.	256	258	GAC	604	606	GAC	208;207;208	G;A;C	196;194;196	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5004	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2934	169.9	1	SNP	p	S87W	0	.	.	259	261	AGT	607	609	AGT	207;207;206	A,C;G;T	193,1;192;188	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5004	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2934	169.9	1	SNP	p	S87R	0	.	.	259	261	AGT	607	609	AGT	207;207;206	A,C;G;T	193,1;192;188	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5004	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2934	169.9	1	SNP	p	S87I	0	.	.	259	261	AGT	607	609	AGT	207;207;206	A,C;G;T	193,1;192;188	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5004	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2934	169.9	1	SNP	p	S88P	0	.	.	262	264	TCC	610	612	TCC	206;206;205	T;C;C	191;190;191	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4050	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2689	150.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1542	1544	GGC	202;202;201	G;G;C	190;190;186	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3594	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2604	137.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1288	1290	GCA	196;199;202	G;C;A	179;186;186	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3594	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2604	137.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1291	1293	ATC	203;204;205	A;T;C	187;188;186	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3594	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2604	137.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1303	1305	GTG	213;213;213	G;T;G	190;189;191	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3594	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2604	137.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1303	1305	GTG	213;213;213	G;T;G	190;189;191	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3594	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2604	137.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1807	1809	ACC	197;198;200	A;C;C	182;184;185	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3594	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2604	137.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1861	1863	GCG	177;174;170	G;C,G;G	152;135,1;145	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3594	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2604	137.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1861	1863	GCG	177;174;170	G;C,G;G	152;135,1;145	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3594	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2604	137.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1984	1986	GGC	129;129;128	G,T,C;G;C	118,1,1;119;120	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3594	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2604	137.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1993	1995	GGC	127;128;126	G;G;C,T	121;122;118,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3594	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2604	137.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2011	2013	CCG	112;116;116	C,G;C;G	91,3;94;95	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5156	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3131	164.1	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1679	1681	CTG	189;187;186	C;T;G	173;169;172	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2332	porA	1146	1146	99.83	porA.l15.c17.ctg.1	1868	124.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	604	604	C	161	C	152	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	G38E	NONSYN	112	114	GGA	323	325	GAA	214;213;212	G;A;A	205;204;201	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	E48G	NONSYN	142	144	GAA	353	355	GGA	217;218;219	G;G,T;A	206;203,2;208	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	T87A	NONSYN	259	261	ACT	470	472	GCT	195;196;198	G;C;T	180;184;181	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	T89S	NONSYN	265	267	ACC	476	478	AGC	197;198;203	A;G;C	181;183;187	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	.	MULTIPLE	358	359	AA	568	569	CG	176;175	C;G	167;166	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	.	MULTIPLE	361	362	GA	571	573	CAG	173;174;172	C;A;G,A	165;165;161,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	N122K	NONSYN	364	366	AAC	575	577	AAA	176;175;174	A;A;A	169;169;165	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	K143E	NONSYN	427	429	AAA	638	640	GAA	179;179;185	GAA,GA;A;A	171,1;169;174	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	V151A	NONSYN	451	453	GTA	662	664	GCA	208;212;212	G;C;A,C	195;199;197,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	N212D	NONSYN	634	636	AAT	845	847	GAT	200;201;206	G;A;T	187;190;195	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	D213G	NONSYN	637	639	GAT	848	850	GGT	203;204;203	G;G;T	190;192;189	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	I218M	NONSYN	652	654	ATA	863	865	ATG	189;189;187	A;T;G	180;178;175	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	T256A	NONSYN	766	768	ACA	977	979	GCA	179;177;179	G;C;A	176;172;176	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	W257T	NONSYN	769	771	TGG	980	982	ACG	177;178;182	A;C;G	175;176;177	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	R258G	NONSYN	772	774	CGT	983	985	GGG	179;181;179	G;G;G	175;177;177	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	A259V	NONSYN	775	777	GCT	986	988	GTT	179;180;177	G;T;T	176;175;171	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1046	1048	GTA	221;223;223	G;T;A,G	195;198;199,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1085	1087	ACT	220;222;226	A;C;T	203;207;207	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1091	1093	GAT	223;225;228	G;A;T	207;207;208	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1103	1105	CAC	236;231;232	C,T;A;C	216,1;213;217	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	1	SNP	p	G120K	1	.	.	358	360	AAG	568	570	CGG	176;175;175	C;G;G	167;166;166	porB1b.WHO_Z_02266c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	1	SNP	p	A121D	1	.	.	361	363	GAC	571	574	CGC	173;172;173	C;G,A;C	165;161,1;164	porB1b.WHO_Z_02266c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2494	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1395	175.9	1	SNP	p	D121N	0	.	.	361	363	GAC	571	574	CGC	173;172;173	C;G,A;C	165;161,1;164	porB1b.WHO_Z_02266c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9120	rpoB	4179	4179	100.0	rpoB.l6.c30.ctg.1	4852	187.3	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1974	1976	CAT	224;226;224	C,A;A;T	208,1;210;208	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1002	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	999	99.2	1	SNP	p	V57M	1	.	.	169	171	ATG	513	515	ATG	186;187;186	A;T;G	179;179;178	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
